Dr Olivier Govaere Professor Dina Tiniakos Professor Alastair Burt Marco Zaki Dr Luca Miele et al. | Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease | 2024 |
|
Dr Massimo Younes Dr Olivier Govaere Dr Dina Tiniakos Professor Alastair Burt Marco Zaki et al. | Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? | 2022 |
|
Marco Zaki Dr Ahmed Mahdi Dr Gillian Patman Anna Whitehead Joao Mauricio et al. | Key features of the environment promoting liver cancer in the absence of cirrhosis | 2021 |
|
Professor Fiona Oakley Marco Zaki Professor Derek Mann
| TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms | 2021 |
|
Dr Julie Worrell Dr Jack Leslie Dr Graham Smith Marco Zaki Dr Hannah Paish et al. | cRel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosis | 2020 |
|
Dr Jack Leslie Dr Marina Garcia Macia Dr Saimir Luli Dr Julie Worrell William Reilly et al. | c-Rel orchestrates energy-dependant epithelial and macrophage reprogramming in fibrosis | 2020 |
|
Dr Massimo Younes Dr Olivier Govaere Dr Luca Miele Dr Dina Tiniakos Professor Alastair Burt et al. | Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease | 2020 |
|
Dr Massimo Younes Dr Olivier Govaere Dr Dina Tiniakos Professor Alastair Burt Marco Zaki et al. | Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease | 2020 |
|
Dr Hannah Paish Lee Reed Helen Brown Mark Bryan Dr Olivier Govaere et al. | A bioreactor technology for modelling fibrosis in human and rodent precision-cut liver slices | 2019 |
|
Dr Eva Moran Salvador Dr Ashwin Sivaharan Laura Sabater Marco Zaki Amber Knox et al. | Fibrogenic Activity of MECP2 is Regulated by Phosphorylation in Hepatic Stellate Cells | 2019 |
|
Professor Helen Reeves Marco Zaki Professor Chris Day
| Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD | 2016 |
|
Marco Zaki Professor Helen Reeves
| The genetic heterogeneity of hepatocellular carcinoma and the implications for personalised medicine | 2016 |
|